Is Novartis AG An Up-And-Coming Cancer Powerhouse?

Recent oncology deals

Novartis’s (NVS) recent deals bode well for robust growth in its oncology business.

Novartis acquired oncology products from GlaxoSmithKline (GSK). The deal completed on March 2, 2015.

Novartis entered into a strategic alliance with Aduro Biotech (ADRO) on March 30, 2015.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news